文献速递性腺与生殖内分泌肥胖与代谢综合征

多囊卵巢综合征女性的妊娠期体重增加:一项对照研究

Gestational Weight Gain in Women With Polycystic Ovary Syndrome: A Controlled Study.
PubMed 文献 · J Clin Endocrinol Metab · 2018-01-01

这项前瞻性队列研究纳入多囊卵巢综合征(PCOS)孕妇164例和排卵正常对照176例,评估诊断和孕前体重对妊娠期体重增加(GWG)及围产结局的影响。结果显示孕前正常体重或超重的PCOS女性GWG多于对照,而肥胖组无差异;各组妊娠期糖尿病、子痫前期和出生体重无显著差异;孕前BMI是GWG最强预测因素。

要点

  • 孕前正常体重的PCOS女性孕早期和孕中期GWG均多于对照。
  • 孕前超重的PCOS女性孕中期GWG多于对照,肥胖组无差异。
  • 孕前BMI每增加1 kg/m²,GWG减少0.62磅。

核心结论

  • 孕前正常体重或超重的PCOS女性GWG多于排卵正常对照。
  • 在正常体重、超重和肥胖组内,PCOS与对照的围产期并发症发生率无显著差异。
  • 孕前BMI是GWG最强的预测因素。

研究设计与样本

  • 前瞻性队列研究,纳入来自不孕治疗的PCOS单胎妊娠164例和排卵正常对照176例。

主要发现

  • 孕前正常体重的PCOS女性孕早期GWG比对照多2.3磅(95%CI 0.3至4.3;P=0.02)。
  • 孕前正常体重的PCOS女性孕中期结束时GWG比对照多4.2磅(95%CI 0.7至7.7;P=0.02)。
  • 孕前超重的PCOS女性孕中期结束时GWG比对照多5.2磅(95%CI 0.2至10.2;P=0.04)。
  • 孕前肥胖的PCOS女性与对照在整个孕期体重增加相似。
  • 在正常体重、超重和肥胖组内,子痫前期和妊娠期糖尿病患病率及出生体重在PCOS与对照间无差异。

临床怎么用

  • 对孕前正常体重或超重的PCOS女性应关注妊娠期体重增加管理。
  • 孕前BMI可用于识别GWG增加风险较高的PCOS女性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Women with polycystic ovary syndrome (PCOS) have increased risk for pregnancy complications, possibly related to pre-existing obesity and excessive gestational weight gain (GWG). OBJECTIVES: To assess the contributions of diagnosis and preconception weight on GWG and perinatal outcomes. RESEARCH DESIGN AND METHODS: Prospective cohort study of singleton pregnancies in PCOS (n = 164) and ovulatory controls (n = 176) from infertility treatment. MAIN OUTCOME MEASURES: GWG, birthweight, pregnancy complications. RESULTS: From preconception baseline, normal-weight women with PCOS gained 2.3 pounds more during the first trimester (95% CI, 0.3 to 4.3; P = 0.02), and by the end of the second trimester, 4.2 pounds more than controls (95% CI, 0.7 to 7.7; P = 0.02). Women who were overweight with PCOS gained significantly more weight than did controls by the end of the second trimester (5.2 pounds; 95% CI, 0.2 to 10.2; P = 0.04), whereas women with obesity and PCOS and control women had similar weight gain throughout pregnancy. Within normal-weight, overweight, and obese groups, prevalence of pre-eclampsia and gestational diabetes did not differ between the PCOS and control groups, nor was there a difference in birthweight. Preconception body mass index (BMI) was significantly associated with GWG; for every 1-kg/m2 increase in preconception BMI, GWG decreased by 0.62 pounds (95% CI, -0.85 to -0.40; P < 0.001). CONCLUSIONS: Women with PCOS who are of normal weight or are overweight before conception experience more GWG than do ovulatory controls. Within normal-weight, overweight, and obese groups, rates of perinatal complications do not significantly differ between women with PCOS and controls. Preconception BMI is the strongest predictor of GWG.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Kent J, Dodson WC, Kunselman A, et al. Gestational Weight Gain in Women With Polycystic Ovary Syndrome: A Controlled Study. J Clin Endocrinol Metab. 2018. PMID: 30085187. doi:10.1210/jc.2017-02764

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。